Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Maison Solutions, Dada, Future FinTech, and AlloVir and Encourages Investors to Contact the Firm
Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
- Stockholders have until the deadlines below to petition the court to serve as lead plaintiff.
- Additional information about each case can be found at the link provided.
- Specifically, AlloVir said it was discontinuing the posoleucel Phase 3 studies after pre-planned analyses concluded they wouldn’t meet their primary endpoints.
- For more information on the AlloVir class action go to: https://bespc.com/cases/ALVR